374 related articles for article (PubMed ID: 22098829)
21. Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib.
Janeway KA; Albritton KH; Van Den Abbeele AD; D'Amato GZ; Pedrazzoli P; Siena S; Picus J; Butrynski JE; Schlemmer M; Heinrich MC; Demetri GD
Pediatr Blood Cancer; 2009 Jul; 52(7):767-71. PubMed ID: 19326424
[TBL] [Abstract][Full Text] [Related]
22. Is exon mutation analysis needed for adjuvant treatment of gastrointestinal stromal tumor?
Sendur MA; Ozdemir NY; Akinci MB; Uncu D; Zengin N; Aksoy S
World J Gastroenterol; 2013 Jan; 19(1):144-6. PubMed ID: 23326179
[TBL] [Abstract][Full Text] [Related]
23. Management of gastrointestinal stromal tumors.
Hueman MT; Schulick RD
Surg Clin North Am; 2008 Jun; 88(3):599-614, vii. PubMed ID: 18514701
[TBL] [Abstract][Full Text] [Related]
24. Molecular response prediction in gastrointestinal stromal tumors.
Cassier PA; Blay JY
Target Oncol; 2010 Mar; 5(1):29-37. PubMed ID: 20361266
[TBL] [Abstract][Full Text] [Related]
25. [Chemotherapy and target-therapy of gastrointestinal tumors call for development of pathology].
Shen L
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):438-9. PubMed ID: 17845753
[No Abstract] [Full Text] [Related]
26. Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy.
Heinrich MC; Corless CL
J Surg Oncol; 2005 Jun; 90(3):195-207; discussion 207. PubMed ID: 15895440
[TBL] [Abstract][Full Text] [Related]
27. [Clinical and molecular characterization of gastrointestinal stromal tumors (GIST)].
Mac K; Wójcik M
Postepy Hig Med Dosw (Online); 2007 Jun; 62():272-81. PubMed ID: 18542042
[TBL] [Abstract][Full Text] [Related]
28. Update on the biology and therapy of gastrointestinal stromal tumors.
D'Amato G; Steinert DM; McAuliffe JC; Trent JC
Cancer Control; 2005; 12(1):44-56. PubMed ID: 15668652
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal stromal tumors: imatinib and beyond.
Schnadig ID; Blanke CD
Curr Treat Options Oncol; 2006 Nov; 7(6):427-37. PubMed ID: 17032555
[TBL] [Abstract][Full Text] [Related]
30. KIT mutations in GIST.
Fletcher JA; Rubin BP
Curr Opin Genet Dev; 2007 Feb; 17(1):3-7. PubMed ID: 17208434
[TBL] [Abstract][Full Text] [Related]
31. [Resistance and treatment strategy of gastrointestinal stromal tumor target therapy].
Lu W; Lu WQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Mar; 15(3):309-12. PubMed ID: 22454182
[TBL] [Abstract][Full Text] [Related]
32. High-risk CD117-positive gastrointestinal stromal tumor of the colon in a 12-year-old girl: adjuvant treatment with imatinib mesylate.
Okur A; Oguz A; Karadeniz C; Pinarli FG; Ozen O; Ekinci O
Tumori; 2012; 98(2):59e-62e. PubMed ID: 22678007
[TBL] [Abstract][Full Text] [Related]
33. Current research and treatment for gastrointestinal stromal tumors.
Lim KT; Tan KY
World J Gastroenterol; 2017 Jul; 23(27):4856-4866. PubMed ID: 28785140
[TBL] [Abstract][Full Text] [Related]
34. Molecular pathobiology of gastrointestinal stromal sarcomas.
Corless CL; Heinrich MC
Annu Rev Pathol; 2008; 3():557-86. PubMed ID: 18039140
[TBL] [Abstract][Full Text] [Related]
35. [Gastrointestinal stromal tumour (GIST): current standards in multimodal management].
Reichardt P; Reichardt A
Zentralbl Chir; 2011 Aug; 136(4):359-63. PubMed ID: 21863513
[TBL] [Abstract][Full Text] [Related]
36. [Gastrointestinal stromal tumors].
Ridolfini MP; Cassano A; Ricci R; Rotondi F; Berardi S; Cusumano G; Pacelli F; Doglietto GB
Ann Ital Chir; 2011; 82(2):97-109. PubMed ID: 21688472
[TBL] [Abstract][Full Text] [Related]
37. Hits and misses in targeting pediatric cancers.
Bernstein ML
Pediatr Blood Cancer; 2009 Jul; 52(7):751-2. PubMed ID: 19185009
[No Abstract] [Full Text] [Related]
38. [Evidence-based treatment of gastrointestinal stromal tumor (GIST) with tyrosine kinase inhibitors-imatinib and sunitinib].
Nishida T; Omori T; Ueshima S
Gan To Kagaku Ryoho; 2011 May; 38(5):733-7. PubMed ID: 21566432
[TBL] [Abstract][Full Text] [Related]
39. Clinical, radiological, and pathological findings in four children with gastrointestinal stromal tumors of the stomach.
Sauseng W; Benesch M; Lackner H; Urban C; Kronberger M; Gadner H; Höllwarth M; Spuller E; Aschauer M; Horcher E
Pediatr Hematol Oncol; 2007; 24(3):209-19. PubMed ID: 17454792
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of kinase inhibitor resistance mechanisms in GIST.
Liegl B; Kepten I; Le C; Zhu M; Demetri GD; Heinrich MC; Fletcher CD; Corless CL; Fletcher JA
J Pathol; 2008 Sep; 216(1):64-74. PubMed ID: 18623623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
